morpholinoanthracycline mx2 has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miyamoto, K; Shinkai, H; Takahashi, H; Tokiwa, T; Uchida, T | 1 |
1 other study(ies) available for morpholinoanthracycline mx2 and Adenocarcinoma
Article | Year |
---|---|
Comparative pharmacokinetics of KRN8602, a new morpholino anthracycline, and adriamycin in tumor-bearing mice.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Brain Chemistry; Carubicin; Cell Survival; Chromatography, High Pressure Liquid; Colonic Neoplasms; Doxorubicin; Female; Intestine, Small; Kidney; Leukemia P388; Liver; Lung; Mice; Myocardium; Neoplasm Transplantation; Spleen; Tissue Distribution; Tumor Cells, Cultured | 1996 |